France· FR:69962765
ERLOTINIB VIATRIS 100 mg, comprimé pelliculé
A medicinal product containing chlorhydrate d'erlotinib, registered in France by VIATRIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'ERLOTINIB
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093011095930 plaquette(s) aluminium OPA : polyamide orienté PVC-Aluminium de 1 comprimé(s)EUR 694.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'erlotinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsErlotinib Amarox 100 mg filmomhulde tablettenAmarox Pharma B.V.
- United StatesErlotinibAurobindo Pharma Limited
- FinlandErlotinib AvansorAvansor Pharma Oy
- SwedenErlotinib Avansor 100 mg Filmdragerad tablettAvansor Pharma Oy
- SpainERLOTINIB CIPLA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGCipla Europe
- BelgiumErlotinib EG 100 mgEG
- CzechiaERLOTINIB KRKAKrka, d.d., Novo mesto, Novo mesto
- PolandErlotinib KrkaKrka, d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Belgium · Erlotinib Sandoz
- Bulgaria · Ерлотиниб Актавис, Ерлотиниб Крка
- Cyprus · Erlotinib Remedica
- Czechia · Erlotinib Krka, Erlotinib Teva
- Germany · Erlotev, Erlotinib Axiromed
- Denmark · Erlotinib "stada", Erlotinib Krka
- Estonia · Erlotinib Viatris
- Spain · Erlotinib Sandoz, Erlotinib Tarbis
- Finland · Erlotinib Krka, Erlotinib Stada
- United Kingdom (Northern Ireland) · Erlotinib Amarox, Erlotinib Glenmark
- Greece · Erlotinib Faran, Erlotinib Teva
- Croatia · Erlotinib Alpha-Medical, Erlotinib Krka
- Hungary · Erlotinib Actavis, Erlotinib Krka
- Iceland · Erlotinib Krka, Erlotinib Teva
- Italy · Erlotinib Mylan, Erlotinib Sandoz
- Liechtenstein · Tarceva
- Lithuania · Erlotinib Viatris, Varlota
- Latvia · Erlotinib Sandoz, Erlotinib Viatris
- Netherlands · Erlotinib Accordpharma, Erlotinib Amarox
- Norway · Erlotinib Krka, Tarceva
- Poland · Erlotinib Zentiva
- Portugal · Erlotinib Mylan, Erlotinib Qritou
- Romania · Erlotinib Krka, Erlotinib Viatris
- Sweden · Erlotinib Krka, Erlotinib Medical Valley
- Slovenia · Erlotinib Krka, Erlotinib Teva
- Slovakia · Erlotinib Sandoz, Erlotinib Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8ee4eef-2b70-4c14-bd6d-42513f4eb7d7 GET /v1/drugs/e8ee4eef-2b70-4c14-bd6d-42513f4eb7d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69962765",
"date_amm": "2018-01-15",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE D'ERLOTINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'erlotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.